TY - JOUR T1 - Unlicenced cannabis-based product use in adult palliative medicine JF - BMJ Supportive & Palliative Care JO - BMJ Support Palliat Care DO - 10.1136/bmjspcare-2021-003012 SP - bmjspcare-2021-003012 AU - Mark Howard AU - Jannah Harrison Y1 - 2021/04/01 UR - http://spcare.bmj.com/content/early/2021/03/31/bmjspcare-2021-003012.abstract N2 - Little is known about the prevalence of unlicenced cannabis-based product use in adult palliative care patients in the UK. Research in other jurisdictions where medicinal cannabis is legal has documented challenges with integration into clinical practice.1 The scheduling of these drugs in the UK changed in 2018.2 There remain few randomised controlled trials to support their use, which contributes to ongoing barriers to prescribing. At a hospice in London, we have been increasingly questioned by patients and families about the benefits of unlicenced forms of these products. Their usage appeared to be increasing in our geographical area. Anecdotally, they were … ER -